Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Tudor Investment Corporation »

Parabilis Medicines shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Tudor Investment Corporation

Quarter filed	Position value	Share count	Share price at filing
2026-06-30	$1.2M	44k	27.37

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)

Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)

Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)

Spdr Gold Shares - US ETP ETF Option Call Option (GLD)

Nvidia Corp - US Equity (NVDA)

Micron Technology Inc - US Equity (MU)

Microsoft Corp - US Equity (MSFT)

Ishares Core S&P 500 Etf - US ETP ETF Option Call Option (IVV)

Tesla Inc - US Equity (TSLA)

Ishares Iboxx High Yield Corporate Bond Etf - US E ETF Option Put Option (HYG)

State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)

State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)

Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)

Advanced Micro Devices Inc - US Equity (AMD)

Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Parabilis Medicines

RA Capital Management

Arch Venture Corp

venBio Partners

Cormorant Asset Management

Regeneron Pharmaceuticals

Farallon Capital Management

Frazier Life Sciences Management

Deerfield Management Company

General Catalyst Group Management

General Atlantic

View all funds holding Parabilis Medicines

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z